What the Science Says About the Health Benefits of Vitamins and Supplements
From multivitamins and melatonin to fiber and fish oil, Americans who are trying to boost their health and immunity have a plethora of supplements to choose from. An estimated 58% of U.S. adults ages 20 and over take dietary supplements, according to the U.S. Centers for Disease Control and Prevention, and the supplement industry is valued at more than $30 billion a year. Supplement use has been growing rapidly over the past few decades along with the wellness industry. “The popular belief is that a supplement is going to be helpful for promoting health,” says Fang Fang Zhang, a professor at Tufts University&rs...
Source: TIME: Health - April 28, 2022 Category: Consumer Health News Authors: Sandeep Ravindran Tags: Uncategorized Diet & Nutrition healthscienceclimate Source Type: news

The Petri Dish: Flagship appoints new CEO-partners, Ginkgo partners on another spinout
Here's The Petri Dish, a roundup of news that may get overlooked amid the influx of health care happenings. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 14, 2022 Category: Health Management Authors: Rowan Walrath Source Type: news

Ginkgo Biloba
Title: Ginkgo BilobaCategory: MedicationsCreated: 3/15/2022 12:00:00 AMLast Editorial Review: 3/15/2022 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - March 15, 2022 Category: Drugs & Pharmacology Source Type: news

Ginkgo Bioworks, Broad Institute rush to aid in hunt for omicron in the U.S.
As health authorities race to figure out where the omicron variant of the coronavirus is spreading in the U.S., two local organizations are working to aid in the effort. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 3, 2021 Category: Biotechnology Authors: Rowan Walrath Source Type: news

VC Firm 11.2 Capital Raises $101 Million To Back More ‘Deep Tech’ Companies Like Ginkgo Bioworks And Hinge Health
Las Vegas-based Shelley Zhuang was an early investor in Cruise, Ginkgo Bioworks and Hinge Health. Now she has $101,010,101 for a second "deep tech" fund. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 1, 2021 Category: Pharmaceuticals Authors: Alex Konrad, Forbes Staff Tags: Venture Capital /venture-capital Innovation /innovation Healthcare /healthcare Science /science Money /money Investing /investing Editors' Pick editors-pick technology Source Type: news

Spinout launches with $78M to bioengineer beauty products
After two years in the labs of Ginkgo Bioworks Holdings Inc. as an entrepreneur-in-residence, Jasmina Aganovic is striking out on her own as CEO of a new startup at the intersection of biotech and beauty: Arcaea. Founded in March as Kalo Ingredients, Arcaea publicly launched Wednesday with a $78 million Series A round, placing it squarely among the largest Series A rounds this year among Massachusetts life sciences companies. Cascade Investment L.L.C., Viking Global, CHANEL, Givaudan and Wittington… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 29, 2021 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news

Ginkgo Bioworks rises on first day of NYSE debut
Ginkgo raised about $1.6 billion through its public offering. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 17, 2021 Category: American Health Authors: Rowan Walrath Source Type: news

Ginkgo Bioworks rises on first day of NYSE debut
Ginkgo raised about $1.6 billion through its public offering. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 17, 2021 Category: Biotechnology Authors: Rowan Walrath Source Type: news

Ginkgo Bioworks rises on first day of NYSE debut
Ginkgo raised about $1.6 billion through its public offering, which was accomplished via a reverse merger with a special-purpose acquisition company, or SPAC, called Soaring Eagle Acquisition Corp. It's one of the largest in biotech history. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 17, 2021 Category: American Health Authors: Rowan Walrath Source Type: news

In vivo toxicity assessment of 4'-O-methylpyridoxine from Ginkgo biloba seeds: growth, hematology, metabolism, and oxidative parameters - Zhu JP, Gong H, Labreche F, Kou XH, Wu CE, Fan GJ, Li TT, Wang JH.
4'-O-methylpyridoxine (MPN), a recognized antivitamin B(6) compound, is a potentially poisonous substance found in Ginkgo biloba seeds and leaves. In this work, the body weights, histopathological changes, plasma vitamin B(6) (VB(6)), biochemical parameter... (Source: SafetyLit)
Source: SafetyLit - August 25, 2021 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news

Ginkgo Bioworks CEO touts lofty vision in first-ever earnings call
In the company's first earnings call as a soon-to-be-publicly traded firm after its merger with a special-purpose acquisition company, Ginkgo Bioworks' CEO and co-founder Jason Kelly didn't spend most of his time focused on finances. Rather, he spent much of the call explaining to analysts the business model for the 12-year-old biotech company in terms more appropriate for a technology startup. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 19, 2021 Category: American Health Authors: Rowan Walrath Source Type: news

The Petri Dish: Vertex CEO joins Ginkgo's board, Moderna steps into cancer
While some in the life sciences industry create drugs and devices to tackle the Covid-19 pandemic, their colleagues are busy as ever raising money, testing new drugs, expanding facilities and more. Here's The Petri Dish, a roundup of news that may get overlooked amid the influx of Greater Boston life sciences and health care happenings. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - August 5, 2021 Category: Health Management Authors: Rowan Walrath Source Type: news

The Petri Dish: Vertex CEO joins Ginkgo's board, Moderna steps into cancer
While some in the life sciences industry create drugs and devices to tackle the Covid-19 pandemic, their colleagues are busy as ever raising money, testing new drugs, expanding facilities and more. Here's The Petri Dish, a roundup of news that may get overlooked amid the influx of Greater Boston life sciences and health care happenings. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 5, 2021 Category: Biotechnology Authors: Rowan Walrath Source Type: news

Ginkgo Bioworks' food-focused spinout raises $226M to get products on the table
Since its founding in early 2019, Motif FoodWorks has been tinkering with ways to engineer plant-based foods so they more closely mirror traditional animal-based ones: tweaking texture to mimic the pull of melted cheese, beefing up the nutrients in plant-based milk so it's as nutritional as cow's milk. Now, armed with an eye-popping $226 million in new funding, Motif is ready to get its products on the dinner table. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 16, 2021 Category: Biotechnology Authors: Rowan Walrath Source Type: news

Ginkgo Bioworks' food-focused spinout raises $226M to get products on the table
Since its founding in early 2019, Motif FoodWorks has been tinkering with ways to engineer plant-based foods so they more closely mirror traditional animal-based ones: tweaking texture to mimic the pull of melted cheese, beefing up the nutrients in plant-based milk so it's as nutritional as cow's milk. Now, armed with an eye-popping $226 million in new funding, Motif is ready to get its products on the dinner table. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 16, 2021 Category: Health Management Authors: Rowan Walrath Source Type: news